Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIA Lung Carcinoma”

200 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 200 results

Testing effectiveness (Phase 2)Looking for participantsNCT05286957
What this trial is testing

MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC

Who this might be right for
NSCLC
The First Affiliated Hospital of Zhengzhou University 60
Testing effectiveness (Phase 2)Looking for participantsNCT04789681
What this trial is testing

Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial

Who this might be right for
Lung CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+10 more
M.D. Anderson Cancer Center 50
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Ended earlyNCT05397171
What this trial is testing

A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours

Who this might be right for
Urinary Bladder NeoplasmsColorectal CancerCarcinoma, Non-Small-Cell Lung
AstraZeneca 17
Testing effectiveness (Phase 2)Looking for participantsNCT04616209
What this trial is testing

Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Precision Biotech Taiwan Corp. 24
Testing effectiveness (Phase 2)Study completedNCT02154399
What this trial is testing

EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 28
Large-scale testing (Phase 3)Study completedNCT00324805
What this trial is testing

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

Who this might be right for
Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage IIA Lung Non-Small Cell Carcinoma AJCC v7Stage IIB Lung Non-Small Cell Carcinoma AJCC v7+1 more
National Cancer Institute (NCI) 1,501
Not applicableActive Not RecruitingNCT02194738
What this trial is testing

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Who this might be right for
Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage II Lung Non-Small Cell Cancer AJCC v7Stage IIA Lung Cancer AJCC v8+4 more
National Cancer Institute (NCI) 8,300
Testing effectiveness (Phase 2)Study completedNCT03717155
What this trial is testing

Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC

Who this might be right for
Squamous Non-Small Cell Lung Cancer
Merck KGaA, Darmstadt, Germany 43
Testing effectiveness (Phase 2)Study completedNCT03568656
What this trial is testing

Study to Evaluate CCS1477 in Advanced Tumours

Who this might be right for
Metastatic Castration-Resistant Prostate CancerMetastatic Breast CancerNon-small Cell Lung Cancer+1 more
CellCentric Ltd. 220
Early research (Phase 1)WithdrawnNCT02059967
What this trial is testing

Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC

Who this might be right for
Adenocarcinoma of the LungLarge Cell Lung CancerSquamous Cell Lung Cancer+4 more
Virginia Commonwealth University
Testing effectiveness (Phase 2)Study completedNCT00963807
What this trial is testing

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 26
Not applicableActive Not RecruitingNCT01817192
What this trial is testing

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)

Who this might be right for
Non-Small Cell Lung Cancer
Razor Genomics 420
Not applicableWithdrawnNCT05412875
What this trial is testing

Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung

Who this might be right for
Head and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaStage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8+15 more
Ohio State University Comprehensive Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT02201992
What this trial is testing

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Who this might be right for
ALK Gene RearrangementALK Gene TranslocationALK Positive+5 more
ECOG-ACRIN Cancer Research Group 166
Testing effectiveness (Phase 2)Study completedNCT00004160
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Who this might be right for
Lung Cancer
University of Alabama at Birmingham 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT03433469
What this trial is testing

Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

Who this might be right for
Stage I Non-Small Cell Lung CancerStage IA Non-Small Cell Lung CancerStage IB Non-Small Cell Lung Cancer+4 more
University of California, San Francisco 27
Testing effectiveness (Phase 2)Study completedNCT00367679
What this trial is testing

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLung Cancer, Non-Small Cell
GlaxoSmithKline 35
Testing effectiveness (Phase 2)Study completedNCT01844791
What this trial is testing

An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Oncozyme Pharma Inc. 25
Early research (Phase 1)Study completedNCT01854684
What this trial is testing

Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung CarcinomaStage IIB Non-Small Cell Lung Carcinoma+2 more
Roswell Park Cancer Institute 8
Load More Results